| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 10.73% | 20.9% | 10.96% |
Franklin Growth Opportunities Fund delivered strong Q2 2026 performance, returning 20.9% versus 17.05% for the Russell 3000 Growth Index, driven primarily by stock selection in information technology. The fund's concentrated position in Micron Technology was a leading contributor as the memory chipmaker surged past $1 trillion market capitalization on strong AI-related demand and long-term supply agreements. An off-benchmark holding in SpaceX also contributed positively following its IPO. The fund maintains a fundamentally driven quality bias with a multi-cap approach, owning many mega-cap leaders while remaining underweight relative to highly concentrated benchmarks. The manager's outlook remains positive despite geopolitical risks, expecting robust earnings growth into 2027 to support valuations. The strategy focuses on structural themes shaped by AI and automation producing measurable productivity gains across IT, health care, financials, industrials, and consumer sectors. Limited direct energy exposure mitigates risk from potential oil price increases, though the manager monitors inflation and consumer spending impacts. The fund positions for an innovation-led expansion where disciplined, active management can add value.
The fund pursues a multi-cap growth strategy focused on high-quality franchises with durable competitive advantages and secular tailwinds, particularly in AI-driven productivity themes across multiple sectors.
The manager's view on US equities and the US economy remains positive despite heightened geopolitical risks. The US economy is relatively insulated from rising energy prices, but the manager is monitoring its potential impact on inflation and consumer spending. In an environment where investors should be selective, the focus is on owning high-quality franchises with durable competitive advantages, often supported by secular tailwinds. Corporate earnings growth is expected to remain robust into 2027, providing support to valuations and the overall positive market outlook. The manager expects to see an innovation-led expansion underpinned by quality fundamentals in an environment where disciplined, active management has an advantage.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jun 30 2026 | 2026 Q2 | AAPL, AMZN, APH, AVGO, GOOGL, INSM, LLY, META, MSFT, MU, NVDA | AI, earnings, growth, Mega-cap, Quality, semiconductors, technology, US | - | Franklin Growth Opportunities Fund outperformed in Q2 2026 with a 20.9% return, led by Micron Technology's AI-driven surge and SpaceX's successful IPO. The fund maintains a quality-focused, multi-cap growth strategy concentrated in AI and automation themes producing productivity gains across sectors. Despite geopolitical risks, the manager expects robust earnings growth into 2027 to support continued market strength, favoring high-quality franchises with durable competitive advantages. |
| May 14 2026 | 2026 Q1 | APP, CASY, MSFT | AI, energy, Geopolitical, growth, innovation, large cap, Quality, technology | - | Franklin Growth Opportunities outperformed in Q1 2026 despite tech rotation pressures, benefiting from Microsoft underweight and industrials overweight. Manager remains bullish on AI-driven productivity gains across sectors while focusing on quality franchises with competitive advantages. Monitoring geopolitical energy risks but expects innovation-led expansion with disciplined active management advantage. |
| Nov 5 2025 | 2025 Q3 | AAPL, AMZN, APP, AVGO, AXON, GOOGL, MA, META, MSFT, NFLX, NVDA, RBLX | AI, gaming, growth, large cap, Onshoring, semiconductors, technology, US | - | Franklin Growth Opportunities underperformed in Q3 2025 despite strong US equity markets, hurt by industrials overweight and IT underweight. Manager remains bullish on US structural advantages in AI, semiconductors, and biotechnology. Key holdings include AI beneficiaries like Axon Enterprise and gaming platform Roblox. Strategy focuses on companies leveraging technological innovations for long-term growth amid constructive economic backdrop. |
| Aug 4 2025 | 2025 Q2 | AAPL, AMZN, APP, AVGO, AXON, GOOGL, MA, META, MSFT, NFLX, NVDA, RBLX | AI, gaming, growth, large cap, semiconductors, technology, US | - | Franklin Growth Opportunities Fund underperformed in Q3 2025 despite strong US equity markets, hurt by industrials selection and Apple underweight. The fund maintains conviction in AI transformation across sectors, with secular tailwinds from onshoring, pro-business policies, and technological innovation supporting US market leadership. Economic conditions remain constructive for risk assets. |
| Jun 30 2024 | 2024 Q2 | AAPL, AMZN, GOOGL, LLY, MA, META, MPWR, MSFT, NOW, NVDA | growth, large cap, technology, US | - | Franklin Growth Opportunities Fund targets companies with accelerating growth and above-average profitability potential. The portfolio concentrates in large-cap technology leaders including NVIDIA, Amazon, and Meta. Strong 32.74% annual returns reflect the growth strategy's effectiveness, though concentration and style risks remain key considerations for investors seeking capital appreciation through growth-oriented equity investments. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q2 |
AIAI infrastructure investment cycle remains intact with robust corporate earnings and continued capital expenditure increases. The fund is focused on structural themes shaped by AI producing measurable productivity gains across IT, health care, financials, industrials, and consumer sectors. Memory chipmakers like Micron are in high demand to support AI applications. |
Infrastructure Semiconductors Productivity Automation |
SemiconductorsMicron Technology was a leading contributor to outperformance as shares rose sharply during the period. The memory chipmaker's products are in high demand to support AI applications, and the company passed $1 trillion in market capitalization during the quarter, supported by long-term chip supply agreements with customers. |
Memory AI Supply Agreements | |
SpaceSpaceX contributed positively to relative returns as privately-held shares increased in value following the company's IPO, reflecting strong investor demand and optimism regarding the company's future growth potential. |
IPO Growth | |
QualityThe US Opportunities strategy has an active, fundamentally driven quality bias. The fund's focus is on owning high-quality franchises with durable competitive advantages, often supported by secular tailwinds. The manager expects this positioning to provide an advantage in an environment requiring disciplined, active management. |
Competitive Advantages Secular Tailwinds Active Management | |
EarningsUS economic growth and year-to-date market performance has been supported by strong profit margins and corporate earnings growth. The manager expects earnings growth to remain robust through year-end and into 2027, providing support to valuations and the overall market. |
Profit Margins Valuations Growth | |
BiotechnologyInsmed, a commercial-stage biotech focused on rare diseases, held back relative returns in the health care sector. The company's shares fell after narrowly missing revenue projections, and investors have raised concerns about the launch visibility of Insmed's new lung inflammation drug BRINSUPRI. |
Rare Diseases Revenue Drug Launch | |
IranThe manager is closely monitoring the evolving conflict in Iran. While hostilities appear to have settled, the Strait of Hormuz remains a key variable, with any significant disruption to energy supplies potentially impacting the global growth and inflation outlook. |
Geopolitical Energy Inflation | |
| 2026 Q1 |
AIAdvances in AI and related technologies are transforming industries and creating growth potential for long-term investors. Innovative companies across sectors are harnessing AI to expand profit margins and drive revenue growth. The fund is focused on structural themes shaped by AI and automation, which are producing measurable productivity gains across IT, healthcare, financials, industrials and consumer-facing sectors. |
Artificial Intelligence Automation Productivity Technology Innovation |
EnergyThe Middle East conflict disrupted energy markets, lifting oil prices and adding to inflation risk. The fund is monitoring the rapidly evolving conflict in Iran and the Strait of Hormuz as key variables. While they have limited direct exposure to the energy sector, they are watching how sustained energy price rises could impact the portfolio and inflation. |
Oil Energy Prices Geopolitical Risk Inflation Iran | |
QualityThe Growth Opportunities strategy has an active, fundamentally driven quality bias. In an environment where growth is available but not abundant, their focus is on owning high-quality franchises with durable competitive advantages, often supported by secular tailwinds. They expect an innovation-led expansion underpinned by quality fundamentals. |
Quality Companies Competitive Advantages Fundamentals Franchises Durability | |
| 2025 Q3 |
AIAdvances in AI and related technologies are transforming industries and creating growth potential for long-term investors. Innovative companies across sectors are harnessing AI to expand profit margins and drive revenue growth. The fund sees AI as a key component to digitalization of law enforcement and emergency services through holdings like Axon Enterprise. |
Artificial Intelligence Technology Innovation Digitalization Automation |
OnshoringOnshoring and supply-chain diversification are reviving domestic manufacturing and boosting output, particularly in the advanced industrial and energy markets. This represents a secular tailwind supporting US market leadership in the years ahead. |
Manufacturing Supply Chain Domestic Industrial Reshoring | |
GamingThe fund holds Roblox, an online gaming platform operator that reported strong bookings year-over-year, helped by improved algorithmic discovery and virality of games. The manager has high conviction in Roblox's long-term growth prospects and ability to increase market share in the global gaming market. |
Online Gaming Platform Digital Entertainment Growth Market Share | |
| 2025 Q2 |
AIAdvances in AI and related technologies are transforming industries and creating growth potential for long-term investors. Innovative companies across sectors are harnessing AI to expand profit margins and drive revenue growth. The fund sees AI beneficiaries like Axon Enterprise in law enforcement digitalization and AppLovin's AI-powered advertising technology. |
Artificial Intelligence Technology Innovation Automation Growth |
OnshoringOnshoring and supply-chain diversification are reviving domestic manufacturing and boosting output, particularly in advanced industrial and energy markets. Apple's plans to build a US manufacturing plant exemplify this trend to reduce China dependence and secure lower tariffs. |
Manufacturing Supply Chain Domestic Tariffs China | |
GamingThe fund maintains high conviction in Roblox's long-term growth prospects and its ability to increase market share in the global gaming market. The online gaming platform reported strong bookings growth helped by improved algorithmic discovery and game virality. |
Online Gaming Platform Growth Market Share Digital |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| No Elevator Pitches found | ||||||||||
| TICKER | COMMENTARY |
|---|---|
| MU | Micron Technology was a leading contributor to outperformance. Shares of the memory chipmaker continued to rise sharply during the period as their products are in high demand to support AI applications. The company passed $1 trillion in market capitalisation during the quarter, supported by long-term chip supply agreements with their customers. |
| INSM | Insmed, a commercial-stage biotech focused on rare diseases, held back relative returns in the health care sector. The company's shares fell after narrowly missing revenue projections. Investors have also raised concerns about the launch visibility of Insmed's new lung inflammation drug BRINSUPRI. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||
